Differences in NMDA receptor expression during human development determine the response of neurons to HIV-Tat-mediated neurotoxicity

E. A. Eugenin, J. E. King, J. E. Hazleton, E. O. Major, Michael V. L. Bennett, R. Suzanne Zukin, Joan W. Berman

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

HIV infection of the CNS can result in neurologic dysfunction in a significant number of infected individuals. NeuroAIDS is characterized by neuronal injury and loss, yet there is no evidence of HIV infection in neurons. Thus, neuronal damage and dropout are likely due to indirect effects of HIV infection of other CNS cells, through elaboration of inflammatory factors and neurotoxic viral proteins, including the viral transactivating protein tat. We and others demonstrated that tat induces apoptosis in differentiated mature human neurons. We now demonstrate that the high level of tat toxicity observed in human neurons involves specific developmental stages that correlate with N-Methyl-d-Aspartate receptor (NMDAR) expression, and that tat toxicity is also dependent upon the species being analyzed. Our results indicate that tat treatment of primary cultures of differentiated human neurons with significant amounts of NMDAR expression induces extensive apoptosis. In contrast, tat treatment induces only low levels of apoptosis in primary cultures of immature human neurons with low or minimal expression of NMDAR. In addition, tat treatment has minimal effect on rat hippocampal neurons in culture, despite their high expression of NMDAR. We propose that this difference may be due to low expression of the NR2A subunit. These findings are important for an understanding of the many differences among tissue culture systems and species used to study HIV-tat-mediated toxicity.

Original languageEnglish (US)
Pages (from-to)138-148
Number of pages11
JournalNeurotoxicity Research
Volume19
Issue number1
DOIs
StatePublished - Jan 2011

Fingerprint

Human Development
N-Methyl-D-Aspartate Receptors
Neurons
HIV
HIV Infections
Toxicity
Viral Proteins
Apoptosis
tat Gene Products
Tissue culture
Neurologic Manifestations
Rats
aspartic acid receptor
Wounds and Injuries

Keywords

  • Dementia
  • Glutamate
  • HAND
  • HIV-1
  • NeuroAIDS
  • NMDA

ASJC Scopus subject areas

  • Neuroscience(all)
  • Toxicology

Cite this

Differences in NMDA receptor expression during human development determine the response of neurons to HIV-Tat-mediated neurotoxicity. / Eugenin, E. A.; King, J. E.; Hazleton, J. E.; Major, E. O.; Bennett, Michael V. L.; Zukin, R. Suzanne; Berman, Joan W.

In: Neurotoxicity Research, Vol. 19, No. 1, 01.2011, p. 138-148.

Research output: Contribution to journalArticle

@article{987d36039c994f198fc648d6b34128d8,
title = "Differences in NMDA receptor expression during human development determine the response of neurons to HIV-Tat-mediated neurotoxicity",
abstract = "HIV infection of the CNS can result in neurologic dysfunction in a significant number of infected individuals. NeuroAIDS is characterized by neuronal injury and loss, yet there is no evidence of HIV infection in neurons. Thus, neuronal damage and dropout are likely due to indirect effects of HIV infection of other CNS cells, through elaboration of inflammatory factors and neurotoxic viral proteins, including the viral transactivating protein tat. We and others demonstrated that tat induces apoptosis in differentiated mature human neurons. We now demonstrate that the high level of tat toxicity observed in human neurons involves specific developmental stages that correlate with N-Methyl-d-Aspartate receptor (NMDAR) expression, and that tat toxicity is also dependent upon the species being analyzed. Our results indicate that tat treatment of primary cultures of differentiated human neurons with significant amounts of NMDAR expression induces extensive apoptosis. In contrast, tat treatment induces only low levels of apoptosis in primary cultures of immature human neurons with low or minimal expression of NMDAR. In addition, tat treatment has minimal effect on rat hippocampal neurons in culture, despite their high expression of NMDAR. We propose that this difference may be due to low expression of the NR2A subunit. These findings are important for an understanding of the many differences among tissue culture systems and species used to study HIV-tat-mediated toxicity.",
keywords = "Dementia, Glutamate, HAND, HIV-1, NeuroAIDS, NMDA",
author = "Eugenin, {E. A.} and King, {J. E.} and Hazleton, {J. E.} and Major, {E. O.} and Bennett, {Michael V. L.} and Zukin, {R. Suzanne} and Berman, {Joan W.}",
year = "2011",
month = "1",
doi = "10.1007/s12640-010-9150-x",
language = "English (US)",
volume = "19",
pages = "138--148",
journal = "Neurotoxicity Research",
issn = "1029-8428",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Differences in NMDA receptor expression during human development determine the response of neurons to HIV-Tat-mediated neurotoxicity

AU - Eugenin, E. A.

AU - King, J. E.

AU - Hazleton, J. E.

AU - Major, E. O.

AU - Bennett, Michael V. L.

AU - Zukin, R. Suzanne

AU - Berman, Joan W.

PY - 2011/1

Y1 - 2011/1

N2 - HIV infection of the CNS can result in neurologic dysfunction in a significant number of infected individuals. NeuroAIDS is characterized by neuronal injury and loss, yet there is no evidence of HIV infection in neurons. Thus, neuronal damage and dropout are likely due to indirect effects of HIV infection of other CNS cells, through elaboration of inflammatory factors and neurotoxic viral proteins, including the viral transactivating protein tat. We and others demonstrated that tat induces apoptosis in differentiated mature human neurons. We now demonstrate that the high level of tat toxicity observed in human neurons involves specific developmental stages that correlate with N-Methyl-d-Aspartate receptor (NMDAR) expression, and that tat toxicity is also dependent upon the species being analyzed. Our results indicate that tat treatment of primary cultures of differentiated human neurons with significant amounts of NMDAR expression induces extensive apoptosis. In contrast, tat treatment induces only low levels of apoptosis in primary cultures of immature human neurons with low or minimal expression of NMDAR. In addition, tat treatment has minimal effect on rat hippocampal neurons in culture, despite their high expression of NMDAR. We propose that this difference may be due to low expression of the NR2A subunit. These findings are important for an understanding of the many differences among tissue culture systems and species used to study HIV-tat-mediated toxicity.

AB - HIV infection of the CNS can result in neurologic dysfunction in a significant number of infected individuals. NeuroAIDS is characterized by neuronal injury and loss, yet there is no evidence of HIV infection in neurons. Thus, neuronal damage and dropout are likely due to indirect effects of HIV infection of other CNS cells, through elaboration of inflammatory factors and neurotoxic viral proteins, including the viral transactivating protein tat. We and others demonstrated that tat induces apoptosis in differentiated mature human neurons. We now demonstrate that the high level of tat toxicity observed in human neurons involves specific developmental stages that correlate with N-Methyl-d-Aspartate receptor (NMDAR) expression, and that tat toxicity is also dependent upon the species being analyzed. Our results indicate that tat treatment of primary cultures of differentiated human neurons with significant amounts of NMDAR expression induces extensive apoptosis. In contrast, tat treatment induces only low levels of apoptosis in primary cultures of immature human neurons with low or minimal expression of NMDAR. In addition, tat treatment has minimal effect on rat hippocampal neurons in culture, despite their high expression of NMDAR. We propose that this difference may be due to low expression of the NR2A subunit. These findings are important for an understanding of the many differences among tissue culture systems and species used to study HIV-tat-mediated toxicity.

KW - Dementia

KW - Glutamate

KW - HAND

KW - HIV-1

KW - NeuroAIDS

KW - NMDA

UR - http://www.scopus.com/inward/record.url?scp=78650526759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650526759&partnerID=8YFLogxK

U2 - 10.1007/s12640-010-9150-x

DO - 10.1007/s12640-010-9150-x

M3 - Article

VL - 19

SP - 138

EP - 148

JO - Neurotoxicity Research

JF - Neurotoxicity Research

SN - 1029-8428

IS - 1

ER -